Accueil › Cancer du sein triple négatif › Illinois › Chicago
Essais cliniques pour Cancer du sein triple négatif à Chicago, IL
16 études pour Cancer du sein triple négatif recherchent des participants dans et autour de Chicago (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- University of Chicago Hospital, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
Recrutement en coursPhase 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Recrutement en coursPhase 3
- University of Illinois Cancer Center ( Site 0044), Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Recrutement en coursPhase 1
- Northwestern University Feinberg School of Medicine, Chicago
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Recrutement en coursPhase 3
- Northwestern Medicine, Chicago
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
SMP-3124LP in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Northwestern Medicine Cancer Center, Chicago
- The University of Chicago, Chicago
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Recrutement en coursPhase 2/3
- Local Institution - 0280, Chicago
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- Northwestern University, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
Recrutement en coursPhase 1
- The University of Chicago Medical Center (UCMC), Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Recrutement en coursPhase 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Study of XB010 in Subjects With Solid Tumors
Recrutement en coursPhase 1
- University of Chicago Medical Center, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Recrutement en coursPhase 1/2
- Northwestern Memorial Hospital, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Recrutement en coursPhase 2
- University of Chicago, Chicago
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Recrutement en coursPhase 2
- University of Chicago Medical Center, Chicago
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Recrutement en coursPhase 1
- UChicago Medicine Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Recrutement en coursPhase 1
- University of Chicago, Chicago
Essais pour Cancer du sein triple négatif dans d'autres villes
- Houston, TX42 études
- New York City, NY31 études
- Nashville, TN28 études
- Los Angeles, CA27 études
- Boston, MA26 études
- San Antonio, TX23 études
- St. Louis, MO21 études
- Arlington, VA20 études
- Atlanta, GA20 études
- Dallas, TX18 études
- Columbus, OH16 études
- Grand Rapids, MI15 études
Autres études à Chicago
- Cancer du poumon non à petites cellules61 études
- Cancer du sein59 études
- Cancer (tous types)51 études
- Cancer métastatique45 études
- Cancer de la prostate45 études
- Cancer du poumon41 études
- Obésité41 études
- Cancer de l'ovaire36 études
- Cancer colorectal34 études
- Accident vasculaire cérébral34 études
- Insuffisance cardiaque31 études
- Surpoids29 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.